Ingevity Corporation
General ticker "NGVT" information:
- Sector: Materials
- Industry: Chemicals - Specialty
- Capitalization: $1.7B (TTM average)
Ingevity Corporation follows the US Stock Market performance with the rate: 69.0%.
Estimated limits based on current volatility of 1.5%: low 65.70$, high 67.66$
Factors to consider:
- Total employees count: 1600 as of 2024
- China accounted for 13.1% of revenue in the fiscal year ended 2024-12-31
- US accounted for 52.3% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Dependence on key customers, Cybersecurity threats, Geopolitical risks, Labor/talent shortage/retention, Environmental regulations
- Current price 15.6% above estimated high
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [31.66$, 52.38$]
- 2025-12-31 to 2026-12-31 estimated range: [35.29$, 57.24$]
Financial Metrics affecting the NGVT estimates:
- Negative: with PPE of 11.5 at the end of fiscal year the price was high
- Positive: Operating profit margin, % of 18.48 > 18.33
- Negative: negative Net income
- Positive: 6.63 < Operating cash flow per share per price, % of 8.64
- Positive: Industry inventory ratio change (median), % of -0.24 <= -0.18
- Positive: -14.19 < Investing cash flow per share per price, % of -5.34
- Positive: 2.95 < Industry operating profit margin (median), % of 5.52
- Negative: Industry operating cash flow per share per price (median), % of 4.99 <= 5.42
- Negative: Shareholder equity ratio, % of 9.65 <= 19.35
- Negative: Industry earnings per price (median), % of 2.45 <= 4.45
Short-term NGVT quotes
Long-term NGVT plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $1,615.70MM | $1,692.10MM | $1,406.40MM |
| Operating Expenses | $1,346.10MM | $1,435.70MM | $1,146.50MM |
| Operating Income | $269.60MM | $256.40MM | $259.90MM |
| Non-Operating Income | $0.00MM | $-266.50MM | $-795.50MM |
| Interest Expense | $61.80MM | $93.30MM | $97.80MM |
| R&D Expense | $30.30MM | $31.80MM | $28.10MM |
| Income(Loss) | $269.60MM | $-10.10MM | $-535.60MM |
| Taxes | $58.00MM | $-4.70MM | $-105.30MM |
| Profit(Loss)* | $211.60MM | $-5.40MM | $-430.30MM |
| Stockholders Equity | $698.30MM | $631.40MM | $195.20MM |
| Inventory | $335.00MM | $308.80MM | $226.80MM |
| Assets | $2,736.50MM | $2,623.30MM | $2,022.60MM |
| Operating Cash Flow | $313.40MM | $205.10MM | $128.60MM |
| Capital expenditure | $142.50MM | $109.80MM | $77.60MM |
| Investing Cash Flow | $-551.90MM | $-77.30MM | $-79.50MM |
| Financing Cash Flow | $48.10MM | $-99.90MM | $-70.20MM |
| Earnings Per Share** | $5.50 | $-0.15 | $-11.85 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.